4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-24-000049
Chief Innovation Officer sold 4,578 shares at $7.68 ($35,159)
- Chief Innovation Officer acquired 18,675 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
DeVinney Erick Wayne · Chief Innovation Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-16 | Exercise or conversion : show line 1 in the form | +3,000 | 166,377 | D | ||
| 2024-03-21 | Sale : show line 2 in the form | −716 | $7.68 | $5,499 | 165,661 | D |
| 2024-03-16 | Exercise or conversion : show line 3 in the form | +2,950 | 168,611 | D | ||
| 2024-03-21 | Sale : show line 4 in the form | −721 | $7.68 | $5,537 | 167,890 | D |
| 2024-03-16 | Exercise or conversion : show line 5 in the form | +12,725 | 180,615 | D | ||
| 2024-03-21 | Sale : show line 6 in the form | −3,141 | $7.68 | $24,123 | 177,474 | D |
| Open-market sales · 4,578 sh · avg $7.68 · $35,159 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-16 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −3,000 | 0 | D |
| 2024-03-16 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −2,950 | 2,950 | D |
| 2024-03-16 | Exercise or conversion : show line 9 in the form Restricted Stock Units | −12,725 | 12,725 | D |
Loading xslF345X05/wk-form4_1711417219.xml…